107 related articles for article (PubMed ID: 2161468)
1. [Histological localization of TAG72 in gastric cancers and a clinico-pathological study of the CA72-4 serum values].
Konishi F; Matzunou H; Konishi K; Yamamichi N
Gan No Rinsho; 1990 May; 36(6):691-9. PubMed ID: 2161468
[TBL] [Abstract][Full Text] [Related]
2. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical studies on tumor associated carbohydrate antigens in gastric cancers of different histological stages].
Nakasaki H; Hanaue H; Miyaji M; Ogoshi K; Tajima T; Mitomi T; Hakomori S
Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1458-64. PubMed ID: 1337575
[TBL] [Abstract][Full Text] [Related]
4. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
Molinolo A; Simpson JF; Thor A; Schlom J
Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774
[TBL] [Abstract][Full Text] [Related]
5. [CA72 -4 (TAG72)].
Mizumoto Y; Kyo S; Takakura M; Nakamura M; Inoue M
Nihon Rinsho; 2010 Jul; 68 Suppl 7():717-9. PubMed ID: 20963906
[No Abstract] [Full Text] [Related]
6. [Clinical study on tissue polypeptide antigen (TPA) in gastric cancer].
Kanauchi M; Sawai F; Hirayama T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K
Gan No Rinsho; 1985 Sep; 31(11):1367-71. PubMed ID: 2999464
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of CA72-4 as a tumor marker in patients with gastric cancer].
Ubukata H; Katano M; Motohashi G; Kasuga T; Takemura A; Tabuchi T; Tabuchi T
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1821-4. PubMed ID: 14619529
[TBL] [Abstract][Full Text] [Related]
8. [The clinical usefulness of serum CA72-4 analysis in patients with ovarian cancer].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):585-9. PubMed ID: 2754289
[TBL] [Abstract][Full Text] [Related]
9. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.
Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S
Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823
[TBL] [Abstract][Full Text] [Related]
10. [Levels of circulating tumor-associated glycoprotein (TAG-72) in patients with carcinoma using a novel tumor marker, CA 72-4].
Ohuchi N; Matoba N; Taira Y; Takahashi K; Sakai N; Sato K; Fujita N; Mochizuki F; Nishihira T; Mori S
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2767-72. PubMed ID: 3166366
[TBL] [Abstract][Full Text] [Related]
11. The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA19-9 and CEA.
Kodama I; Koufuji K; Kawabata S; Tetsu S; Tsuji Y; Takeda J; Kakegawa T
Int Surg; 1995; 80(1):45-8. PubMed ID: 7657491
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of tumor markers biochip C12 system in the diagnosis of gastric cancer and the strategies for improvement: analysis of 100 cases.
Chen C; Chen LQ; Chen LD; Yang GL; Li Y
Hepatogastroenterology; 2008; 55(84):991-7. PubMed ID: 18705314
[TBL] [Abstract][Full Text] [Related]
13. [Tumor markers and gastric cancer. TAG-72 is the most useful].
Fernández-Llamazares J; Piñol M; Encabo G; Gelonch J
Med Clin (Barc); 1998 Dec; 111(20):800. PubMed ID: 9922976
[No Abstract] [Full Text] [Related]
14. Detection of gastric cancer and premalignant lesions by novel marker glycoprotein 87 using monoclonal antibody Adnab-9.
Qiao SX; Yuan M; Liu YL; Lin XS; Zhang XP; Tobi M
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1095-9. PubMed ID: 14578149
[TBL] [Abstract][Full Text] [Related]
15. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
[TBL] [Abstract][Full Text] [Related]
16. [An immunohistochemical evaluation of Warthin's tumor using the monoclonal anti-human lung adenocarcinoma antibody KM-93 and the anti-human gastric carcinoma antibody KM-231].
Tsuji T; Kimura Y; Murakami T; Sasaki K; Shinozaki F
Gan No Rinsho; 1990 Jun; 36(7):783-6. PubMed ID: 2355463
[TBL] [Abstract][Full Text] [Related]
17. [Monoclonal antibody NCC-ST-439 in gastric cancer tissue].
Kamata T; Yoneumura Y; Sugiyama K; Yamaguchi A; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1989 Feb; 90(2):222-7. PubMed ID: 2747606
[TBL] [Abstract][Full Text] [Related]
18. [Mucohistochemical studies of CEA producing and non-producing stomach cancers].
Iguchi K; Tanaka T; Yamagishi H; Inaba S; Fujimori C; Kurioka H; Kobayashi M; Hashimoto I
Gan No Rinsho; 1983 Aug; 29(9):971-80. PubMed ID: 6194317
[TBL] [Abstract][Full Text] [Related]
19. [Gastroscopy plus cytology for the diagnosis of gastric cancer or precancerous diseases--report of 127 cases].
Zhao HY
Zhonghua Zhong Liu Za Zhi; 1986 Mar; 8(2):115-7. PubMed ID: 3021413
[TBL] [Abstract][Full Text] [Related]
20. [Multi-antibody combined determination of lymph node micrometastasis in patients with gastric cancer].
Wang GY; Wang SJ; Li Y; Wang LL; Wang XL; Song ZC; Fan LQ
Ai Zheng; 2004 May; 23(5):559-63. PubMed ID: 15142454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
